Prescription Drugs

• What You Need to Know About the Drug Price Fight in Those TV Ads

  July 12, 2023: In recent months ominous ads about prescription drugs have flooded the TV airwaves. Perhaps by design, it’s not always clear who’s sponsoring the ads or why. Or, for that matter, why now? The short answer is that Congress is paying attentio...Read more >

• KFF Health News: Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients

  July 07, 2023: The FDA on Thursday gave full approval to what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, critics see it as the unfortunat...Read more >

• Following Merck, U.S. Chamber of Commerce, Bristol Myers Squibb and PhRMA Sue Administration Over Drug Price Negotiation

  June 26, 2023: The U.S. Chamber of Commerce, Bristol Myers Squibb and PhRMA, the drug industry’s trade association, have filed three separate lawsuits against the Biden administration to block Medicare’s authority to negotiate lower drug prices. They joined Mer...Read more >

• America’s Work Force Union Podcast: Inflation Reduction Act Under Fire From Major Drug Company

  June 16, 2023: June 16, 2023 Alliance Executive Director Richard Fiesta joined America's Workforce Union Podcast to discuss Merck's lawsuit challenging Medicare drug price negotiation, which was included in the Inflation Reduction Act. You can click above or...Read more >

• Merck Lawsuit Over Drug Price Negotiation Reflects Industry Greed and Disregard for Seniors and Taxpayers

  June 06, 2023: The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding Merck’s filing a lawsuit to block Medicare from negotiating lower drug prices on behalf of the American people.  “Merck�...Read more >

• Pfizer CEO Comment on Drug Price Negotiation Reflects Industry Greed, Arrogance and Disregard for Patients

  May 12, 2023: The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding Pfizer CEO Albert Bourla’s statement that the federal government’s plans to negotiate drug prices for Medicare amount to "ne...Read more >

• Biden-Harris Administration Acts to Lower Prices for 27 Drugs

  March 21, 2023: On Wednesday, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced 27 prescription drugs for which Medicare Part B beneficiary coinsurances may be lower from April 1 – June 30,...Read more >

• New Retiree Voting Record Report Released

  March 13, 2023:  Scores Congress on Votes Including the Landmark “Inflation Reduction Act” Washington, DC – The Alliance for Retired Americans released its 2022 Congressional Voting Record, which scored each U.S. Senator and Representative on critical reti...Read more >

• Insulin Prices Cut for More Patients as Eli Lilly Caves to Pressure

  March 07, 2023: Drug corporation Eli Lilly announced Wednesday that it will cap out-of-pocket patient costs for its two most popular insulin drugs, Humalog and Humulin, at $35 a month. Patients with private insurance and who use participating pharmacies will pay the...Read more >

• Battle Over ‘Orphan Drugs’ Leads to Higher Drug Prices

  February 27, 2023: An “orphan drug” is a designation that rewards drug corporations for developing treatments for rare diseases. When a drugmaker wins approval for an orphan drug, the company is entitled to seven years of exclusive rights to the marketplace, which ...Read more >